MRSA Screening (Elective Patients)

Similar documents
A patient s guide to. MRSA - Methicillin Resistant Staphylococcus Aureus

About MRSA. MRSA (sometimes referred to as a superbug) stands for meticillin resistant Staphylococcus aureus.

Advice for those affected by MRSA outside of hospital If you have MRSA this booklet provides information to help manage your day-to-day life

Advice for those affected by MRSA outside of hospital

MRSA. Patient Screening Information

MRSA CROSS INFECTION RISK: IS YOUR PRACTICE CLEAN ENOUGH?

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs)

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

MRSA Information for patients, staff and relatives

MRSA Screening Programme National Targeted Rollout. MRSA Screening

NHS GRAMPIAN MRSA POLICY FOR COMMUNITY SETTINGS JUNE 2003

Screening for MRSA / MSSA and CPO within the Kent Kidney Care Centre

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15

Living with MRSA Learning how to control the spread of Methicillin-Resistant Staphylococcus Aureus (MRSA)

Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CONTROLLED DOCUMENT

Today s Agenda: 9/30/14

Multidrug Resistant Organisms (MDROs) and Clostridium difficile (C. diff)

To guide safe and appropriate selection of antibiotic therapy for Peritoneal Dialysis patients.

Management of Meticillin resistant Staphylococcus

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

So Why All the Fuss About Hand Hygiene?

Healthcare-associated infections surveillance report

Multi-Drug Resistant Organisms (MDRO)

Infection control in intensive care. Sandra Fairley Senior Nurse, Neurocritical Care

Conflict of interest: We have no conflict of interest to report on this topic of SSI reduction for total knees.

Responders as percent of overall members in each category: Practice: Adult 490 (49% of 1009 members) 57 (54% of 106 members)

In-Service Training Program. Managing Drug-Resistant Organisms in Long-Term Care

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents

MRSA: How to Keep This Deadly Super Bug From Infecting You

MRSA in the United Kingdom status quo and future developments

Preventing Surgical Site Infections. Edward L. Goodman, MD September 16, 2013

Role of the nurse in diagnosing infection: The right sample, every time

Staph and MRSA Skin Infections Fact Sheet for Schools

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

Nosocomial Antibiotic Resistant Organisms MRSA & VRE

Healthcare-associated infections surveillance report

appropriate healthcare professionals employed at my pharmacy. I understand that I am

MRSA Outbreak in Firefighters

MRSA What We Need to Know Sharon Pearce, CRNA, MSN Carolina Anesthesia Associates

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Minims Chloramphenicol

Segment Three - People Cause Problems

EcoHydra Antimicrobial Handwash. Product Overview. Physical Properties. Product Description. Regulatory Compliance. Key Features and Benefits

Replaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION

DOG 14 DOGS AND HUMAN HEALTH

Kevin Chapman Infection, Prevention and Control Nurse Ron Forbister Patient Safety Officer. Contents

Healthcare-associated Infections Annual Report December 2018

Antibiotics. Information for patients and carers Pharmacy Department. Patient information leaflet

Prevalence & Risk Factors For MRSA. For Vets

Treatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals

Controlling MRSA in the healthcare setting An achievable goal?

Nosocomial Antibiotic Resistant Organisms

Carbapenemase-Producing Enterobacteriaceae (CPE)

STANDARD OPERATING PROCEDURE #701 MACAQUE RELATED INJURY

General Rules Topicals for Skin Infections Topicals for Allergic Skin Disease Topicals for Seborrhea

2.0 Scope These guidelines refer to all Cheshire Ireland employees, service users, their relatives, carers and visitors.

Carbapenemase-Producing Enterobacteriaceae Multi Drug Resistant Organism Management Procedure. (IPC Manual)

Operational Directives

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Staphylococcus aureus Blood Stream Infection (Bacteraemia) Surveillance. Ceredigion and Mid Wales Trust Data per Bed Days

Risk factors? Insect bites? Hygiene? Household crowding Health literacy

Role of the general physician in the management of sepsis and antibiotic stewardship

REVIEW DATE October 2009

Cellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018

Glycopeptide Resistant Enterococci (GRE) Policy IC/292/10

Package leaflet: Information for the patient. FLUCLOXACILLIN 250MG/5ML ORAL SOLUTION Flucloxacillin

Peri-operative Antibiotic Prophylaxis. 2 nd QI Cycle results Compiled by: Dr Stella Sasha

Questions and answers about methicillin-resistant Staphylococcus aureus (MRSA)

COMMUNITY ASSOCIATED METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS A PRACTICAL GUIDE FOR PRIMARY CARE PRACTITIONERS

Lesson 6: Handwashing and Gloving

Importance of handwashing prior to wound dressings in prevention of nosocomial infection in surgical wards

Hospital Acquired Infections in the Era of Antimicrobial Resistance

Dogs and human health

The role of Infection Control Nurse in Prevention of Surgical Site Infection (SSI) April 2013

Discussion Paper: Antimicrobial Resistance Sept 2014

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

CELLULITIS / SKIN INFECTIONS

with a new course of injections. Most kennels and catteries will insist on seeing proof of regular vaccinations.

Int.J.Curr.Microbiol.App.Sci (2018) 7(1):

Understanding MRSA. 1. MRSA: An Overview The Rise of Antibiotic-Resistant Infections MRSA Infections Are Increasing 30 Among Teenagers

A solution for current veterinary challenges

MRSA. by Melissa Ochs

Version Control Sheet

New horizon on community-acquired methicillin resistant Staphylococcus NTAS MRSA NTAS NTAS

Hand disinfection Topics

Approval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017

AIDS, CANINES AND ZOONOSES: RISKS AND BENEFITS OF VISITS

Can you treat mrsa with amoxicillin

Delayed Prescribing for Minor Infections Resource Pack for Prescribers

Post-operative surgical wound infection

Infection Control and Standard Precautions

The Royal College of Pathologists. Pathology: the science behind the cure. Careers in pathology

Standing Orders for the Treatment of Outpatient Peritonitis

Volume 2; Number 16 October 2008

Policy Forum. Environmental and Professional Hygiene: Toward the Prevention of Drug Resistant Infections

3.0 Treatment of Infection

TABLE OF CONTENTS. 1. Purpose of the WRHA Infection Prevention and Control Manual 2.1 and approval process

PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust

Methicillin Resistant Staphylococcus Aureus (MRSA) Achievement in Al-Mafraq Hospital Abu Dhabi, UAE

Transcription:

What is MRSA? MRSA stands for Meticillin resistant Staphylococcus aureus. It is a type of Staphylococcus aureus bacteria (germ) that is very resistant to antibiotics so infections due to MRSA can be quite difficult to treat. MRSA bacteria can live harmlessly on the skin or in the nose of a person without causing symptoms; this is known as being colonised with MRSA or carrying MRSA. However in some circumstances the bacteria can enter the body and cause infections such as wound, skin, eye and urine infections. Around one in three people carry Staphylococcus aureus, and less than one in ten people coming into contact carry MRSA. What is MRSA Screening? MRSA screening is a test that all patients coming into hospital need to have to identify if they are carrying the MRSA bacterium. The test will be carried out when you are admitted to hospital and will involve a swab being taken from your nose and/or groin, and any cuts or wounds you may have. If you have a urinary catheter, a sample of urine will also be taken from the tube. The swabs/samples will then be tested in the laboratory. What are the benefits of MRSA screening? Infections due to MRSA are more likely to occur when patients are in hospital, being treated with antibiotics or having drips inserted and removed. Screening helps to identify patients who are carrying the MRSA bacterium so they can be treated to prevent them from developing an infection or passing the bacterium to other patients. The test identified nine out of ten people who are carrying MRSA. Are there any risks in taking MRSA screening? There is a risk that the test will produce a negative result even if you are carrying MRSA; this occurs in one in ten patients. The test also does not identify the ordinary Staphylococcus aureus bacterium. Are there any alternative ways of screening for MRSA? There are no alternative ways of screening for MRSA. Page 1

What are the risks of not being screened for MRSA? If you are not screened for MRSA, we cannot identify if you are carrying the bacteria and give you the appropriate treatment to reduce your risk of developing an MRSA infection. When do I get the result? A member of staff will let you know your screening result as soon as possible. What will happen if I am found to be carrying MRSA? If you are found to be carrying MRSA,it does not mean that you are infected with MRSA, only that you are carrying it on your skin. In some cases your surgeon will decide to delay your operation to see if you can be cleared of MRSA, but in many cases the surgery will proceed as normal but you will be given treatment to try and clear the MRSA. This treatment will involve applying an ointment to the inside of your nose and showering and shampooing you hair with an antiseptic soap (a type of soap that helps to reduce the risk of infection). You will be given full instructions on how and when to use these. When you come into hospital for your operation, you may be nursed in a single room on a ward or part of a ward together with other patients who have screened positive for MRSA. Even if your screening result for MRSA is negative, we advise you to use antiseptic washes to shower and shampoo your hair during the 48 hours before your operation. This can be purchased form any pharmacy. Depending on the type of surgery you are having, you may be given a container of antiseptic washes at your pre-operative assessment visit. What are the benefits of treatment? The benefit of this treatment is that it will reduce the risk of you developing an MRSA infection and transmitting it to others. What are the risks of treatment? Your skin could become irritated by the washes if you are allergic to the ingredients and could become dry, red, sore and/or cracked. If this happens, please stop using it and tell the person looking after you (if you are in hospital) or your GP (if you have been discharged). Page 2

What are the risks of not getting treatment? If you do not complete your treatment, there is a small risk of developing an infection and transmitting the bacteria to others. Are there alternative treatments? There are alternative products available to reduce MRSA carriage. However, Sandwell and West Birmingham Hospitals uses the treatments that are nationally recognised and scientifically proven to be effective. These alternatives can be used if you are allergic to the products routinely used. Treatment with antibiotics is also available and your Doctor/Nurse will advise you if this is appropriate for you. How long will I carry MRSA for? Some people may carry the germ for long periods of time whilst others may no longer carry it after they have received treatment. If you develop an infection, your Doctor will know you have carried MRSA in the past and will be able to prescribe the correct antibiotics without delay, but will not mind if you remind them. Are my relatives at risk of catching the germ from me? The MRSA bacterium is not a problem for healthy people and there is no reason why your relatives and friends should keep away from you. However, they should cover any cuts with waterproof plasters and should wash their hands after visiting you. This is to prevent MRSA from spreading. They only need to wear gloves and plastic aprons if they are helping with your care whilst you are in the hospital. For more information on reducing the risk of cross infection, please see the leaflet Helping us to reduce the risk of cross infection. Should I stay away from Work/School? You do not have to stay off work/school if you carry MRSA. If you have an infection, your Doctor might advise you to stay off if you are unwell. If you are unsure please speak to your GP will know your clinical history. If you are a healthcare worker you should inform your Occupational Health Department. Page 3

Contact Details If you have any questions or concerns please speak to the Doctor looking after you, your GP or the hospital or community Infection, Prevention and Control Nurses. Infection, Prevention and Control Service 0121 554 3801 (ask for Infection Prevention &Control Service) Futher Information NHS Choices www.nhs.uk/conditions/mrsa NHS Non Emergency Number 111 For more information about our hospitals and services please see our website: Sandwell and West Birmingham Hospitals www.swbh.nhs.uk Further Infection, Prevention and Control information leaflets can be found on our website, or you can ask a member of staff for a copy. You may find the following leaflets useful: MRSA MRSA Screening (elective patients) Helping us to reduce the risk of cross infection Page 4

Sources used for the information is this leaflet Department of Health, Screening for Meticillin resistant Staphylococcus aureus (MRSA) colonisation. A strategy for NHS trusts: summary of best practice, 2006 (updated 2008) Clinical Infectious Diseases Journal, Randomised controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampicin and oxycycline versus no treatment for the eradication of methicillin resistant Staphylococcus aureus colonisation, 2007. British National Formulary 71, section 13: Skin cleansers, antiseptics and de-sloughing agents: Chlorhexidine, March 2016. If you would like to suggest any amendments or improvements to this leaflet please contact the communications department on 0121 507 5303 or email: swb-tr.swbh-gm-patient-information@nhs.net A Teaching Trust of The University of Birmingham Incorporating City, Sandwell and Rowley Regis Hospitals ML5379 Issue Date: July 2016 Review Date: July 2019 Page 5